Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3 , Pages 277-283, May 2009

Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment

  • Hai-Bo Liu, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • ,
  • Chui-Ze Kong, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • Corresponding Author InformationCorresponding author. Tel.: +86-24-83283433; fax: +86-24-83283433
    • ,
  • Yu Zeng, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • Department of Urology, Kagawa University Faculty of Medicine, Kagawa, Japan
    • ,
  • Xian-Kui Liu, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • ,
  • Jian-Bin Bi, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • ,
  • Yuan-Jun Jiang, M.D.

      Affiliations

    • Department of Urology, The First Hospital of China Medical University, Shenyang, China
    • ,
  • Sheng Han, M.D.

      Affiliations

    • Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China

Received 28 December 2007; received in revised form 10 March 2008; accepted 10 March 2008. published online 16 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(08)00064-1

doi:10.1016/j.urolonc.2008.03.015

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3 , Pages 277-283, May 2009

Article Tools

* Image Usage & Resolution